Skip to content
Screener

Return on equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
46.7%+17.8pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
25.7%-4.5pp
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
22.5%+10.1pp
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
35.7%+2.6pp
AbbVie logo
AbbVieABBV
89%+32.7pp
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-40%+22.3pp

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$602.19M-13.2%
Enterprise value$552.07M

Returns & leverage

See full
Debt / equity
Current ratio22.9×